Skip to Content

Lisdexamfetamine Pregnancy and Breastfeeding Warnings

Lisdexamfetamine is also known as: Vyvanse

Lisdexamfetamine Pregnancy Warnings

Lisdexamfetamine has been assigned to category C by the FDA. Animal studies have not been reported. There are no controlled data in human pregnancy. Lisdexamfetamine is only recommended for use during pregnancy when benefit outweighs risk.

Animal reproduction studies of lisdexamfetamine dimesylate have not been performed. Studies have been performed with the active metabolite of lisdexamfetamine, d-amphetamine, either alone or in combination with l-amphetamine. Animal studies with dextroamphetamine have revealed evidence of embryotoxicity and teratogenicity. In addition, there has been one report of a case of severe congenital bony deformity, tracheoesophageal fistula, and anal atresia (vater association) in a baby born to a woman using dextroamphetamine with lovastatin during the first trimester of pregnancy. Infants born to mothers dependent on amphetamines have an increased risk of premature delivery and low birth weight. These infants may experience symptoms of withdrawal including dysphoria, agitation, weakness, and exhaustion. One study on the affects of methamphetamine abuse on pregnancy outcome reported that body weight, length, and head circumference were significantly decreased in neonates born to mothers who abused methamphetamines during pregnancy. The study also noted that the frequency of congenital anomalies was not significantly increased.

See references

Lisdexamfetamine Breastfeeding Warnings

Amphetamines are excreted into human milk. According to the manufacturer, breast-feeding is not recommended during administration of lisdexamfetamine.

See references

References for pregnancy information

  1. "Product Information. Vyvanse (lisdexamfetamine)." Shire US Inc, Florence, KY.

References for breastfeeding information

  1. "Product Information. Vyvanse (lisdexamfetamine)." Shire US Inc, Florence, KY.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.